Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lysosomal acidic compartment and autophagy machinery represent a complex cellular system responsible for the degradation and recycling of cytoplasmic components to maintain proteostasis (Mindell, 2012; Mizushima & Komatsu, 2011). The lysosome maintains an acidic internal environment (pH 4.5–5.0) through the action of vacuolar-type H+-ATPases (V-ATPases), which is essential for the function of over 60 different acid hydrolases (Forgac, 2007). Autophagy is the process that delivers cargo, such as damaged organelles or protein aggregates, to these lysosomes via double-membraned vesicles called autophagosomes (Nixon, 2013). In oncology, this machinery is frequently exploited by tumor cells to survive nutrient deprivation and therapy-induced stress, whereas its dysfunction is a hallmark of neurodegenerative diseases like Alzheimer's and Parkinson's (Amaravadi et al., 2019; Nixon, 2013). Pharmacological agents like hydroxychloroquine and chloroquine target this system by accumulating in lysosomes and increasing their pH, thereby inhibiting the final stages of autophagic degradation (Mauthe et al., 2018). Other drugs, such as rapamycin, modulate the system by inhibiting mTORC1 to induce autophagy (Mizushima & Komatsu, 2011). Therapeutic challenges include the potential for systemic toxicity and the double-edged sword nature of autophagy, which can be either cytoprotective or cytotoxic depending on the context (Onorati et al., 2018).
Modulation of lysosomal pH, inhibition of V-ATPase proton pumps, or inhibition of ATG-mediated autophagosome formation to alter cellular degradative flux.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosomal acidic compartment and autophagy machinery.